Hydromorphone Hcl Injectable
109 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
109
Total Reports
23
Deaths Reported
2110.0%
Death Rate
Active Ingredients
Hydromorphone Hcl Injectable
Administration Routes
UnknownIntramuscularIntravenousSubcutaneous
Species Affected
Dog 101
Cat 6
Rabbit 2
Most Affected Breeds
Retriever - Labrador 10
Dog (unknown) 8
Chihuahua 8
Crossbred Canine/dog 5
Shepherd (unspecified) 4
Boxer (German Boxer) 4
Shepherd Dog - German 4
Domestic Shorthair 4
Terrier - Bull - American Pit 3
Bulldog - American 3
Most Reported Reactions
Vomiting 14
Death 14
Bradycardia 13
Lack of efficacy - NOS 13
Cardiac arrest 12
Lethargy (see also Central nervous system depression in 'Neurological') 10
Death by euthanasia 8
Anaphylaxis 8
Seizure NOS 7
Elevated total bilirubin 6
Heart block NOS 6
Panting 6
Outcome Breakdown
Recovered/Normal
43 (39.4%)
Ongoing
40 (36.7%)
Died
15 (13.8%)
Euthanized
8 (7.3%)
Outcome Unknown
3 (2.8%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.